- Home
- FOFO vs STRO Comparison
FOFO vs STRO Comparison
Compare FOFO & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOFO
- STRO
- Stock Information
- Founded
- FOFO 2017
- STRO 2003
- Country
- FOFO Hong Kong
- STRO United States
- Employees
- FOFO N/A
- STRO N/A
- Industry
- FOFO
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FOFO
- STRO Health Care
- Exchange
- FOFO Nasdaq
- STRO Nasdaq
- Market Cap
- FOFO 80.2M
- STRO 94.9M
- IPO Year
- FOFO 2025
- STRO 2018
- Fundamental
- Price
- FOFO $10.19
- STRO $0.89
- Analyst Decision
- FOFO
- STRO Hold
- Analyst Count
- FOFO 0
- STRO 7
- Target Price
- FOFO N/A
- STRO $1.97
- AVG Volume (30 Days)
- FOFO 51.0K
- STRO 782.2K
- Earning Date
- FOFO 01-01-0001
- STRO 11-06-2025
- Dividend Yield
- FOFO N/A
- STRO N/A
- EPS Growth
- FOFO N/A
- STRO N/A
- EPS
- FOFO 0.36
- STRO N/A
- Revenue
- FOFO $3,117,608.00
- STRO $105,646,000.00
- Revenue This Year
- FOFO N/A
- STRO $65.48
- Revenue Next Year
- FOFO N/A
- STRO N/A
- P/E Ratio
- FOFO $28.23
- STRO N/A
- Revenue Growth
- FOFO 1597.65
- STRO N/A
- 52 Week Low
- FOFO $4.63
- STRO $0.52
- 52 Week High
- FOFO $68.00
- STRO $3.01
- Technical
- Relative Strength Index (RSI)
- FOFO N/A
- STRO 48.24
- Support Level
- FOFO N/A
- STRO $0.81
- Resistance Level
- FOFO N/A
- STRO $0.95
- Average True Range (ATR)
- FOFO 0.00
- STRO 0.08
- MACD
- FOFO 0.00
- STRO -0.00
- Stochastic Oscillator
- FOFO 0.00
- STRO 53.02
About FOFO Hang Feng Technology Innovation Co. Ltd. Ordinary Shares
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their unique business and investment objectives. Its business consists of two main segments: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting, and Regulatory compliance and governance consulting.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.